SK608989A3 - The composition for transdermal application with gestodene content - Google Patents

The composition for transdermal application with gestodene content Download PDF

Info

Publication number
SK608989A3
SK608989A3 SK608989A SK608989A SK608989A3 SK 608989 A3 SK608989 A3 SK 608989A3 SK 608989 A SK608989 A SK 608989A SK 608989 A SK608989 A SK 608989A SK 608989 A3 SK608989 A3 SK 608989A3
Authority
SK
Slovakia
Prior art keywords
layer
gestodene
composition
skin
optionally
Prior art date
Application number
SK608989A
Other languages
English (en)
Slovak (sk)
Other versions
SK278438B6 (en
Inventor
Clemens Guenther
Ulrich Taeuber
Karin Schmidt-Gollwitzer
Jutta Riedl
Johannes W Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK278438B6 publication Critical patent/SK278438B6/sk
Publication of SK608989A3 publication Critical patent/SK608989A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK608989A 1989-03-29 1989-10-27 The composition for transdermal application with gestodene content SK608989A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19893910578 DE3910578A1 (de) 1989-03-29 1989-03-29 Mittel zur transdermalen applikation enthaltend gestoden

Publications (2)

Publication Number Publication Date
SK278438B6 SK278438B6 (en) 1997-05-07
SK608989A3 true SK608989A3 (en) 1997-05-07

Family

ID=6377622

Family Applications (1)

Application Number Title Priority Date Filing Date
SK608989A SK608989A3 (en) 1989-03-29 1989-10-27 The composition for transdermal application with gestodene content

Country Status (5)

Country Link
CZ (1) CZ277870B6 (pl)
DE (1) DE3910578A1 (pl)
PL (2) PL162410B1 (pl)
RU (1) RU2044541C1 (pl)
SK (1) SK608989A3 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2131822C (en) * 1992-03-21 2002-12-17 Walter Elger Use of estriol for treating climacteric osteoporosis
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
PT1191927E (pt) 1999-07-02 2003-07-31 Lohmann Therapie Syst Lts Sistema de microrreservatorios a base de polissiloxanos e solventes ambifilicos
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
WO2008136699A1 (fr) * 2007-05-04 2008-11-13 Igor Alexandrovich Bazikov Patch transdermique à microcapsules et procédé de fabrication correspondant

Also Published As

Publication number Publication date
PL162400B1 (pl) 1993-11-30
SK278438B6 (en) 1997-05-07
PL287526A1 (en) 1991-10-21
PL282033A1 (en) 1991-03-11
CZ277870B6 (en) 1993-06-16
PL162410B1 (pl) 1993-11-30
DE3910578A1 (de) 1990-10-04
CZ608989A3 (en) 1993-02-17
RU2044541C1 (ru) 1995-09-27

Similar Documents

Publication Publication Date Title
JP3238389B2 (ja) ゲストデン含有の経皮適用のための薬剤
RU2154455C2 (ru) Чрескожные терапевтические системы, содержащие половые стероиды
AU687013B2 (en) Transdermal application agent containing 3-keto-desogestrel
US5858394A (en) Agent for transdermal administration that contains gestodene esters
DD286293A5 (de) Mittel zur transdermalen applikation enthaltend gestoden
SK608989A3 (en) The composition for transdermal application with gestodene content
JPH09508911A (ja) デソゲストレルを含有する経皮適用剤
JPH11509222A (ja) １３−エチル−１７β−ヒドロキシ−１１−メチレン−１８，１９−ジノル−１７α−プレグン−４−エン−２０−イン−３−オンのエステルを含む経皮投与のための剤
JPH04505333A (ja) ロリプラムを含有する皮膚浸透移行性適用剤
JPH09510697A (ja) １４α，１７α−エタノエストラ−１，３，５（１０）−トリエン−３，１７β−ジオールを含有する経皮投与のための薬剤
HUT74616A (en) Agent, intended for transdermal administration, containing 14alfa, 17alfa-ethanoestra-1,3,5(10)-triene-3,17beta-diol
CA2182188A1 (en) Agent, intended for transdermal administration, containing 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol